Literature DB >> 12163444

Isoprenoids as mediators of the biological effects of statins.

James K Liao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12163444      PMCID： PMC151100          DOI： 10.1172/JCI16421

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  38 in total

Review 1.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

2.  An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro.

Authors:  M Aikawa; E Rabkin; S Sugiyama; S J Voglic; Y Fukumoto; Y Furukawa; M Shiomi; F J Schoen; P Libby
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

Review 3.  Molecular bases of the acute coronary syndromes.

Authors:  P Libby
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

Review 4.  New insights into the pharmacodynamic and pharmacokinetic properties of statins.

Authors:  A Corsini; S Bellosta; R Baetta; R Fumagalli; R Paoletti; F Bernini
Journal:  Pharmacol Ther       Date:  1999-12       Impact factor: 12.310

5.  Neuroprotection mediated by changes in the endothelial actin cytoskeleton.

Authors:  U Laufs; M Endres; N Stagliano; S Amin-Hanjani; D S Chui; S X Yang; T Simoncini; M Yamada; E Rabkin; P G Allen; P L Huang; M Böhm; F J Schoen; M A Moskowitz; J K Liao
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

6.  Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.

Authors:  K A Chan; S E Andrade; M Boles; D S Buist; G A Chase; J G Donahue; M J Goodman; J H Gurwitz; A Z LaCroix; R Platt
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

7.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

8.  Effect of pravastatin on outcomes after cardiac transplantation.

Authors:  J A Kobashigawa; S Katznelson; H Laks; J A Johnson; L Yeatman; X M Wang; D Chia; P I Terasaki; A Sabad; G A Cogert
Journal:  N Engl J Med       Date:  1995-09-07       Impact factor: 91.245

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

Review 10.  Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.

Authors:  B G Brown; X Q Zhao; D E Sacco; J J Albers
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690
View more
  128 in total

Review 1.  Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Authors:  John Greenwood; Lawrence Steinman; Scott S Zamvil
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

Review 2.  Statins as potential therapeutic agents in multiple sclerosis.

Authors:  Olaf Stüve; Thomas Prod'homme; Sawsan Youssef; Shannon Dunn; Oliver Neuhaus; Martin Weber; Hans-Peter Hartung; Lawrence Steinman; Scott S Zamvil
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 3.  Inflammation and atherosclerosis.

Authors:  Mehdi H Shishehbor; Deepak L Bhatt
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

4.  Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation.

Authors:  Wen-Han Cheng; Wen-Yu Ho; Chien-Feng Chang; Pei-Jung Lu; Pei-Wen Cheng; Tung-Chen Yeh; Ling-Zong Hong; Gwo-Ching Sun; Michael Hsiao; Ching-Jiunn Tseng
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

5.  Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.

Authors:  Marc-Alexander L T Parent; David A Hottman; Shaowu Cheng; Wei Zhang; Lori L McMahon; Li-Lian Yuan; Ling Li
Journal:  Cell Mol Neurobiol       Date:  2014-04-01       Impact factor: 5.046

6.  New benefits of statin treatment.

Authors:  Guenther Boden
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

Review 7.  [Direct neuronal effects of statins].

Authors:  J Bösel; M Endres
Journal:  Nervenarzt       Date:  2006-03       Impact factor: 1.214

Review 8.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

9.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

Authors:  Jun-ichi Hanai; Peirang Cao; Preeti Tanksale; Shintaro Imamura; Eriko Koshimizu; Jinghui Zhao; Shuji Kishi; Michiaki Yamashita; Paul S Phillips; Vikas P Sukhatme; Stewart H Lecker
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.

Authors:  Ping-Yen Liu; Yen-Wen Liu; Li-Jen Lin; Jyh-Hong Chen; James K Liao
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.